OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment
Yaxian Li, Yuejiang Zheng, Shuyi Xu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111944-111944
Closed Access | Times Cited: 5
Yaxian Li, Yuejiang Zheng, Shuyi Xu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111944-111944
Closed Access | Times Cited: 5
Showing 5 citing articles:
Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer
Hao Yuan, Yufeng Zhang, Fengyuan Liu, et al.
Cancer Letters (2025), pp. 217515-217515
Closed Access
Hao Yuan, Yufeng Zhang, Fengyuan Liu, et al.
Cancer Letters (2025), pp. 217515-217515
Closed Access
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy
Linhui Zheng, Wenqi Cai, Ke Yuan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Linhui Zheng, Wenqi Cai, Ke Yuan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Kangzheng Lv, Tianlin He
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Kangzheng Lv, Tianlin He
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
PPAB001, a novel bispecific antibody against CD47 and CD24, enhances anti-PD-L1 efficacy in triple-negative breast cancer via reprogramming tumor-associated macrophages towards M1 phenotype
Yun Yang, Jianqin Li, Jing Zhang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113740-113740
Closed Access | Times Cited: 1
Yun Yang, Jianqin Li, Jing Zhang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113740-113740
Closed Access | Times Cited: 1
